14 results on '"Nishigori, Naoto"'
Search Results
2. Intraluminal lavage to remove exfoliated tumor cells after colorectal endoscopic submucosal dissection
- Author
-
Inoue, Takashi, Fujii, Hisao, Koyama, Fumikazu, Nakamura, Shinji, Ueda, Takeshi, Nishigori, Naoto, Kawasaki, Keijiro, Obara, Shinsaku, Nakamoto, Takayuki, Uchimoto, Kazuaki, Morita, Kohei, Nishikawa, Takeshi, Ohbayashi, Chiho, and Nakajima, Yoshiyuki
- Published
- 2016
- Full Text
- View/download PDF
3. Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI)
- Author
-
Nishigori, Naoto, Koyama, Fumikazu, Nakagawa, Tadashi, Nakamura, Shinji, Ueda, Takeshi, Inoue, Takashi, Kawasaki, Keijirou, Obara, Shinsaku, Nakamoto, Takayuki, Fujii, Hisao, and Nakajima, Yoshiyuki
- Published
- 2016
- Full Text
- View/download PDF
4. Laparoscopic surgery after endoscopic resection for rectal cancer and neuroendocrine tumors
- Author
-
Inoue, Takashi, Nakagawa, Tadashi, Nakamura, Shinji, Ueda, Takeshi, Nishigori, Naoto, Kawasaki, Keijiro, Obara, Shinsaku, Nakamoto, Takayuki, Nakajima, Yoshiyuki, Koyama, Fumikazu, and Fujii, Hisao
- Published
- 2015
- Full Text
- View/download PDF
5. Local recurrence after rectal endoscopic submucosal dissection: a case of tumor cell implantation
- Author
-
Inoue, Takashi, Fujii, Hisao, Koyama, Fumikazu, Nakagawa, Tadashi, Uchimoto, Kazuaki, Nakamura, Shinji, Ueda, Takeshi, Nishigori, Naoto, Kawasaki, Keijiro, Obara, Shinsaku, Nakamoto, Takayuki, and Nakajima, Yoshiyuki
- Published
- 2014
- Full Text
- View/download PDF
6. Erythropoietin attenuates intestinal inflammation and promotes tissue regeneration
- Author
-
Nakamura, Shinji, Sho, Masayuki, Koyama, Fumikazu, Ueda, Takeshi, Nishigori, Naoto, Inoue, Takashi, Nakamoto, Takayuki, Fujii, Hisao, Yoshikawa, Shusaku, Inatsugi, Naoki, and Nakajima, Yoshiyuki
- Subjects
inflammatory bowel disease ,cytokine ,erythropoietin ,tissue regeneration ,intestine ,digestive system diseases - Abstract
Background. The prevalence of inflammatory bowel disease (IBD) is increasing. Since patients usually need long-term treatment and suffer from reduced quality of life, there is a need to develop new therapeutic strategy. The aim of this study was to investigate the therapeutic potential of erythropoietin (EPO) for the treatment of IBD. Methods. Murine colitis was induced by 3.0% Dextran Sulfate Sodium (DSS). Recombinant human EPO (rhEPO) was given to evaluate the anti-inflammatory and regenerative effects on intestinal inflammation. The effect of rhEPO on human colon epithelial cells was also evaluated. Immunohistochemical analysis of EPO receptor was performed in human IBD tissues. Results. While about 62% of control mice with severe colitis induced by 5-day DSS died, 85% of mice treated with rhEPO survived. Histological analysis confirmed that EPO treatment reduced the colonic inflammation. Furthermore, EPO treatment significantly downregulated the local expressions of IFN-γ, TNF-α and E-selectin in the colon, suggesting that the effect was associated with inhibiting local immune activation. In a 4-day DSS-induced colitis model, rhEPO significantly improved the recovery of body weight loss compared to controls. Furthermore, proliferating cell nuclear antigen expression was significantly upregulated in the colon tissue from mice treated with rhEPO compared to controls. In addition, rhEPO increased the growth of cultured human colon epithelial cells in a dose-dependent manner. Furthermore, EPO-receptor expression was confirmed in human IBD colon tissues. Conclusion. Three major functions of EPO, hematopoiesis, anti-inflammation and regeneration, may produce significant effects on intestinal inflammation, therefore suggesting that rhEPO might be useful for IBD., 博士(医学)・乙第1364号・平成27年7月31日, © Informa UK Limited, an Informa Group Company, The definitive version is available at " http://dx.doi.org/10.3109/00365521.2015.1020861 "
- Published
- 2015
7. HVEM expression contributes to tumor progression and prognosis in human colorectal cancer
- Author
-
Inoue, Takashi, Sho, Masayuki, Yasuda, Satoshi, Nishiwada, Satoshi, Nakamura, Shinji, Ueda, Takeshi, Nishigori, Naoto, Kawasaki, Keijiro, Obara, Shinsaku, Nakamoto, Takayuki, Koyama, Fumikazu, Fujii, Hisao, and Nakajima, Yoshiyuki
- Subjects
surgery ,prognosis ,HVEM ,Colorectal cancer ,digestive system diseases ,tumor immunity - Abstract
Background: Herpesvirus entry mediator (HVEM) has been recently suggested to play certain roles in cancer biology. We examined HVEM expression in human colorectal cancer (CRC) to reveal its clinical importance. Materials and Methods: Immunohistochemical staining was carried-out in normal epithelium, benign and malignant lesions. Results: While intense HVEM expression was not observed in normal epithelium and hyperplastic polyps, 24% of adenoma and more than half of CRCs had high HVEM expression. In 234 CRCs, HVEM expression was significantly associated with tumor status and pathological stage. Patients with high HVEM expression had a significantly poorer prognosis than those with low expression. Importantly, HVEM status had an independent prognostic value in CRC. Furthermore, HVEM status was inversely corrected with the presence of tumor-infiltrating T-cells. Conclusion: HVEM may play a critical role in tumor progression and immune evasion, and may also be a novel prognostic marker and potential therapeutic target in human CRC., 博士(医学)・乙第1363号・平成27年7月31日, 発行元の規定により、本文の登録不可。本文は以下のURLを参照 "http://ar.iiarjournals.org/content/35/3/1361.abstract" (※全文閲覧は学内限定)
- Published
- 2015
8. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy
- Author
-
Nishigori, Naoto, Matsumoto, Masanori, Koyama, Fumikazu, Hayakawa, Masaki, Hatakeyama, Kinta, Ko, Saiho, Fujimura, Yoshihiro, and Nakajima, Yoshiyuki
- Subjects
digestive system diseases - Abstract
Oxaliplatin-based chemotherapy is widely used to treat advanced colorectal cancer (CRC). Sinusoidal obstruction syndrome (SOS) due to oxaliplatin is a serious type of chemotherapy-associated liver injury (CALI) in CRC patients. SOS is thought to be caused by the sinusoidal endothelial cell damage, which results in the release of unusually-large von Willebrand factor multimers (UL-VWFMs) from endothelial cells. To investigate the pathophysiology of CALI after oxaliplatin-based chemotherapy, we analyzed plasma concentration of von Willebrand factor (VWF) and the distribution of VWFMs in CRC patients. Twenty-three patients with advanced CRC who received oxaliplatin-based chemotherapy with (n = 6) and without (n = 17) bevacizumab were analyzed. CALI (n = 6) and splenomegaly (n = 9) were found only in patients who did not treated with bevacizumab. Plasma VWF antigen (VWF:Ag) and serum aspartate aminotransferase (AST) levels increased after chemotherapy only in patients without bevacizumab. VWFM analysis in patients who did not receive bevacizumab showed the presence of UL-VWFMs and absence of high molecular weight VWFMs during chemotherapy, especially in those with CALI. In addition, plasma VWF:Ag and AST levels increased after chemotherapy in patients with splenomegaly (n = 9), but not in patients without splenomegaly (n = 14). Histological findings in the liver tissue of patients who did not receive bevacizumab included sinusoidal dilatation and microthrombi in the sinusoids. Many microthrombi were positive for both anti-IIb/IIIa and anti-VWF antibodies. Plasma UL-VWFM levels might be increased by damage to endothelial cells as a result of oxaliplatin-based chemotherapy. Bevacizumab could prevent CALI and splenomegaly through inhibition of VWF-rich platelet thrombus formation., 博士(医学)・乙第1373号・平成28年3月15日, Copyright: © 2015 Nishigori et al. This is an open access article distributed under the terms of the Creative Commons Attribution License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Published
- 2015
9. Mucinous adenocarcinoma associated with a chronic perianal fistula - a review of cases from a single institution.
- Author
-
Koyama F, Nakagawa T, Nakamura S, Ueda T, Nishigori N, Inoue T, Kawasaki K, Obara S, Nakamoto T, Uchimoto K, Fujii H, Kido A, Tanaka Y, Yoshida K, Fujimoto K, Kuwahara M, and Nakajima Y
- Subjects
- Adult, Aged, Chronic Disease, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Rectal Fistula complications, Rectal Fistula surgery, Rectal Neoplasms etiology, Rectal Neoplasms surgery, Retrospective Studies, Adenocarcinoma, Mucinous etiology, Adenocarcinoma, Mucinous surgery, Rectal Fistula pathology, Rectal Neoplasms pathology
- Abstract
Purpose: The purpose of this study was to evaluate the clinicopathological features of mucinous adenocarcinoma associated with perianal fistulas (MAF), to assess the importance of preoperative MRI analysis, and to determine the optimal surgery., Methods: We performed a retrospective analysis of the data from seven patients with MAF treated at our hospital between 2000 and 2013, and herein discuss the importance of preoperative magnetic resonance imaging (MRI) and of radical surgery., Results: The male to female ratio was 5:2, and the mean age of the patients was 63 years old (28-70). The median duration of chronic fistulation was 16 years (5-40). The tumor extension was classified as II+III+IV in five patients and as II+III in 2 patients according to the Sumikoshi classification, as determned by pelvic MRI. The performed surgeries were 3 abdominoperineal resections with sacral resection and 4 pelvic exenterations with sacral resection. Two local recurrences developed in patients with R1 resection, and 1 distant metastasis occurred in 1 patient with R0 resection., Conclusion: For patients with MAF, a curative surgical resection is the only definitive treatment that can be expected to provide a good prognosis. The application of the Sumikoshi classification using MRI may provide a precise assessment of the extension of MAF, which can allow the appropriate surgery to be selected for the patients with MAF.
- Published
- 2014
10. Prophylactic laparoscopic lateral pelvic lymph node dissection for lower rectal cancer: remarking on the vesicohypogastric fascia.
- Author
-
Ueda T, Koyama F, Nakagawa T, Nakamura S, Nishigori N, Inoue T, Kawasaki K, Obara S, Nakamoto T, Uchimoto K, Fujii H, and Nakajima Y
- Subjects
- Humans, Lymphatic Metastasis prevention & control, Rectal Neoplasms pathology, Fasciotomy, Laparoscopy, Lymph Node Excision methods, Rectal Neoplasms surgery
- Abstract
Objective: To introduce the prophylactic laparoscopic lateral pelvic lymph node dissection performing by remarking the vesicohypogastric fascia following total mesorectal excision for patients with advanced lower rectal cancer without radiological evidence of lymph node involvement., Surgical Method: We set 5 ports for conventional laparoscopic rectal surgery. During the prophylactic laparoscopic lateral pelvic lymph node dissection, we retrieved the lymph nodes from the internal iliac area and obturator area. We recognized the pelvic nerve plexus, vesicohypogastric fascia (including internal iliac vessels), and parietal fascia (psoas muscle fascia, pubic bone and internal obturator muscle fascia) as the dissection borders from internal to external. Of note, the vesicohypogastric fascia can be recognized under magnified clear vision, and can be preserved by precise dissection, resulting in reduced hemorrhage from the internal iliac vessels and complications such as urinary dysfunction., Conclusion: Prophylactic laparoscopic lateral pelvic lymph node dissection after remarking on the vesicohypogastric fascia may contribute to a less invasive surgery compared with conventional laparoscopic lateral pelvic lymph node dissection.
- Published
- 2014
11. Exfoliated Tumor Cells in Intraluminal Lavage Samples after Colorectal Endoscopic Submucosal Dissection: A Pilot Study.
- Author
-
Inoue T, Fujii H, Koyama F, Nakagawa T, Uchimoto K, Nakamura S, Ueda T, Nishigori N, Kawasaki K, Obara S, Nakamoto T, and Nakajima Y
- Subjects
- Aged, Aged, 80 and over, Colonoscopy methods, Colorectal Neoplasms pathology, Dissection methods, Female, Humans, Intestinal Mucosa pathology, Japan, Male, Middle Aged, Pilot Projects, Retrospective Studies, Treatment Outcome, Colonoscopy adverse effects, Colorectal Neoplasms surgery, Dissection adverse effects, Intestinal Mucosa surgery, Neoplasm Seeding, Therapeutic Irrigation
- Abstract
Endoscopic submucosal dissection involves dissecting manipulation performed with tumors in an exposed condition for a long period of time. Thus, there is a risk for implantation of tumor cells. The objectives of this study were to examine exfoliated tumor cells after colorectal endoscopic submucosal dissection and to elucidate the effectiveness of intraluminal lavage to remove these cells. The subjects were 8 patients who had undergone colorectal endoscopic submucosal dissection at our hospital between September and December 2012. A retrospective study was conducted on the cytological findings of intraluminal lavage samples in these patients. Seven of the 8 patients (88%) had exfoliated tumor cells in the lavage samples at the beginning of lavage. Only 3 patients (3 8%) had exfoliated tumor cells after lavage with 300 ml of water. A large number of tumor cells were thought to have exfoliated into the intestinal lumen after endoscopic submucosal dissection. Sufficient intraluminal lavage after colorectal endoscopic submucosal dissection is necessary to remove exfoliated tumor cells.
- Published
- 2014
12. The "sliding door" technique for closure of abdominal wall defects after rectus abdominis musculocutaneous flap transposition.
- Author
-
Nakamoto T, Koyama F, Kobata Y, Nagao M, Nakagawa T, Nakamura S, Ueda T, Nishigori N, Inoue T, Kawasaki K, Obara S, Fujii H, Kido A, Koizumi M, Tanaka Y, and Nakajima Y
- Subjects
- Humans, Male, Middle Aged, Rectal Fistula etiology, Rectal Fistula surgery, Rectal Neoplasms complications, Abdominal Wall surgery, Plastic Surgery Procedures methods, Rectal Neoplasms surgery, Rectus Abdominis surgery, Surgical Flaps
- Abstract
Radical surgery is often necessary in patients with local recurrence of rectal cancer or in those with carcinoma associated with an anal fistula. The surgery may include extended excision of the perineal area and can create a large dead space in the pelvis and a large skin defect, often necessitating reconstruction of the pelvic floor using rectus abdominis musculocutaneous (RAM) flap transposition. Wound dehiscence and incisional hernia are common complications of RAM flap transposition. We report herein our encounter with 3 patients in whom we used a "sliding door" technique for reconstruction of the abdominal wall after the creation of a RAM flap. One patient underwent abdominoperineal resection with sacrectomy and RAM flap transposition; he experienced a postoperative surgical site infection and wound dehiscence, which we urgently repaired by reconstructing the abdominal wall using the sliding door technique. Two other patients underwent posterior pelvic exenteration with sacrectomy and RAM flap transposition. These patients underwent simultaneous abdominal wall reconstruction using the sliding door technique. No patient experienced postoperative pelvic sepsis, wound dehiscence, or incisional hernia. The sliding door technique might be useful for preventing wound dehiscence and incisional hernia in patients undergoing RAM flap transposition.
- Published
- 2013
13. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
- Author
-
Ueda T, Koyama F, Nakagawa T, Nakamura S, Nishigori N, Inoue T, Kawasaki K, Obara S, Nakamoto T, Fujii H, and Nakajima Y
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Pelvic Neoplasms pathology, Postoperative Complications epidemiology, Recurrence, Retrospective Studies, Treatment Outcome, Young Adult, Pelvic Exenteration adverse effects, Pelvic Neoplasms surgery
- Abstract
Objective: The aim of this study was to evaluate the outcomes of patients who underwent extensive pelvic surgery for locally advanced primary or recurrent non-colorectal pelvic malignancies., Patients and Methods: We performed a retrospective review of the medical records of 19 patients with non-colorectal pelvic malignancies who underwent extensive surgery at our institution between January 2005 and May 2013. Overall survival and progression-free survival were estimated using the Kaplan-Meier method and compared using the logrank test., Results: With regard to tumor histology, 6 patients (31.6%) had gynecological tumors, 8( 42.1%) had urological tumors, 2( 10.5%) had sarcomas, and 3( 15.8%) had other malignancies. Total pelvic exenteration was performed in 13 patients (68.4%), and other procedures were performed in 6 patients( 31.6%). For all patients, the median operation time and blood loss were 699 min and 2,930 mL, respectively. Complete tumor resection( R0) was achieved in 13 patients( 68.4%), and 16 patients had complications( 84.2%). The median overall survival was 18.5 months for patients who underwent R0 resection, compared with 7.3 months for those who underwent R1/R2 surgery (p=0.113), and the median progression-free survival was 7.3 months for cases of R0 resection, compared with 2.0 months for cases of R1/R2 surgery (p=0.035)., Conclusion: Our findings indicate that extensive pelvic surgery may be an optimal treatment for some patients with locally advanced primary or recurrent non-colorectal pelvic malignancies. Careful patient selection according to oncological, anatomical, and patient-related factors may improve the outcomes of patients undergoing this extensive, aggressive pelvic surgical procedure.
- Published
- 2013
14. Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer: initial clinical experiences with prophylactic dissection.
- Author
-
Obara S, Koyama F, Nakagawa T, Nakamura S, Ueda T, Nishigori N, Inoue T, Kawasaki K, Nakamoto T, Fujii H, and Nakajima Y
- Subjects
- Humans, Laparoscopy, Lymph Node Excision, Lymphatic Metastasis prevention & control, Rectal Neoplasms pathology, Rectal Neoplasms surgery
- Abstract
Aim: To evaluate the technical feasibility of laparoscopic lateral pelvic lymph node dissection (LPLD) following total mesorectal excision (TME) as prophylaxis for patients with advanced lower rectal cancer but no radiologic evidence of lymph node involvement., Patients and Methods: TME was performed on 30 patients with cT3N1-2M0 lower rectal cancer. LPLD was performed by laparoscopic surgery in 12 patients (LAP group),and open surgery in 18 patients (Open group). Statistical analysis was used to compare the number of harvested lymph nodes, operative time, operative blood loss, transfusion rate, and volume of transfusion between the groups., Results: No significant difference was observed in the number of harvested lymph nodes. Operative time was significantly longer in the LAP group; however, operative blood loss, transfusion rate, and volume of transfusion were significantly lower in the LAP group., Conclusion: Laparoscopic LPLD, when performed by a well-trained laparoscopic team, is safe and feasible in some selected lower rectal cancer patients. This approach has the potential to achieve oncologic lymph node clearance equivalent to open surgical LPLD, and to overcome the cited disadvantages of LPLD, which include greater operative blood loss and urinary dysfunction.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.